Fingerprint
Dive into the research topics where Gerald Fraser is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
I-CARE, a European Prospective Cohort Study Assessing Safety and Effectiveness of Biologics in Inflammatory Bowel Disease
I-CARE Collaborator Group, Mar 2023, In: Clinical Gastroenterology and Hepatology. 21, 3, p. 771-788.e10Research output: Contribution to journal › Article › peer-review
Open Access35 Scopus citations -
Randomised trial and open-label extension study of an anti-interleukin-6 antibody in Crohn's disease (ANDANTE I and II)
Danese, S., Vermeire, S., Hellstern, P., Panaccione, R., Rogler, G., Fraser, G., Kohn, A., Desreumaux, P., Leong, R. W., Comer, G. M., Cataldi, F., Banerjee, A., Maguire, M. K., Li, C., Rath, N., Beebe, J. & Schreiber, S., 1 Jan 2019, In: Gut. 68, 1, p. 40-48 9 p.Research output: Contribution to journal › Article › peer-review
Open Access164 Scopus citations -
The incidence and prevalence of inflammatory bowel disease in the jewish and arab populations of Israel
Zvidi, I., Boltin, D., Niv, Y., Dickman, R., Fraser, G. & Birkenfeld, S., Mar 2019, In: Israel Medical Association Journal. 21, 3, p. 194-197 4 p.Research output: Contribution to journal › Article › peer-review
12 Scopus citations -
Infliximab Reduces Endoscopic, but Not Clinical, Recurrence of Crohn's Disease after Ileocolonic Resection
Regueiro, M., Feagan, B. G., Zou, B., Johanns, J., Blank, M. A., Chevrier, M., Plevy, S., Popp, J., Cornillie, F. J., Lukas, M., Danese, S., Gionchetti, P., Hanauer, S. B., Reinisch, W., Sandborn, W. J., Sorrentino, D., Rutgeerts, P., Debinski, H., Florin, T. & Hetzel, D. & 128 others, , 1 Jun 2016, In: Gastroenterology. 150, 7, p. 1568-1578 11 p.Research output: Contribution to journal › Article › peer-review
Open Access316 Scopus citations -
Ustekinumab as induction and maintenance therapy for Crohn's disease
UNITI-IM-UNITI Study Group, 17 Nov 2016, In: New England Journal of Medicine. 375, 20, p. 1946-1960 15 p.Research output: Contribution to journal › Article › peer-review
Open Access1684 Scopus citations